title: Metformin-induced lactic acidosis in a type 2 diabetic patient with acute renal failure.
abstract: Metformin is a biguanide commonly used in type 2 diabetes mellitus (DM). Lactic acidosis, a potentially life-threatening metabolic disorder, may be due to a number of different causes, including metformin therapy. We present a case of a severe metformin-induced lactic acidosis in a patient with type 2 DM, admitted to the emergency department with a history of dehydration due to diarrhoea and complicated by acute renal failure. Patient complained malaise and severe weakness and was tachypneic (Kussmaul's respiration), agitated and confused, with a Glasgow Coma Scale score of 13/15. Heart rate was 75 b/min and blood pressure 110/80 mmHg. The pH was 6.87, HCO3- 3 mmol/l, lactate 15 mmol/l, potassium 6.9 mEq/l. The renal function was markedly impaired with a creatinine of 9.75 mg/dl, and pancreatic enzymes, amylase and lipase, were also increased in absence of abdominal pain. Patient was treated with intravenous fluids, bicarbonate infusion and haemodialysis with bicarbonate buffered replacement fluid. Clinical conditions improved rapidly, with a progressive normalization of the acid-base balance and the other laboratory data. Authors discuss the pathophysiologic mechanisms of these alterations with particular regard to the role played by metformin as potential cause of lactic acidosis.
authors.affiliation: Unità Operativa Complessa di Medicina e Chirurgia d'Accettazione e d'Urgenza, Azienda Ospedaliera S. Elia, Caltanissetta, Italy. adigrande@yahoo.it
authors.forename: A
authors.initials: A
authors.lastname: Di Grande
authors.forename: F
authors.initials: F
authors.lastname: Vancheri
authors.forename: V
authors.initials: V
authors.lastname: Giustolisi
authors.forename: C
authors.initials: C
authors.lastname: Giuffrida
authors.forename: G
authors.initials: G
authors.lastname: Narbone
authors.forename: M
authors.initials: M
authors.lastname: Licata
authors.forename: C
authors.initials: C
authors.lastname: Le Moli
authors.forename: S
authors.initials: S
authors.lastname: Riccobene
authors.forename: A
authors.initials: A
authors.lastname: Burgio
authors.forename: S
authors.initials: S
authors.lastname: Bartolotta
authors.forename: F
authors.initials: F
authors.lastname: Nigro
authors.forename: V
authors.initials: V
authors.lastname: Cannone
mesh_terms: D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D058186:Acute Kidney Injury / Q000150:complications* / Q000628:therapy; D000368:Aged; D003131:Combined Modality Therapy; D003681:Dehydration / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D003967:Diarrhea / Q000150:complications; D004198:Disease Susceptibility; D004630:Emergencies; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008687:Metformin / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin